FENOFIBRATE

Fenofibrate is also known as lipid modifying agent widely used for the treatment of hyperlipidemia and hypertriglyceridemia and promotes cardiovascular protection through multiple metabolic pathways. Fenofibrate activates peroxisome proliferator activated receptor alpha [PPARα] which is nuclear receptor that regulates lipid metabolism. Fenofibrate increases overall cardiovascular health and decreases fibrinogen, C-reactive protein as well as uric acid levels.

Fenofibrate has broad efficacy and well tolerance level which shows targeted action resulting in low triglyceride levels. It provides long term lipid management and therefore is widely used in oral solid dosage forms such as tablets and capsules.

Chemox Pharma supplies pharma grade Fenofibrate API which helps in development of innovative formulations for effective cardiovascular wellness and good lipid control that results in empowering the fight against dyslipidaemia and overall metabolic and vascular health. Chemox Pharma offers consistent high-quality API and follow WHO-GMP regulated standards.